Clinical Trials on TSC2
Total 11 results
-
Aadi Bioscience, Inc.Approved for marketingTSC1 | TSC2 | PEComa, Malignant | mTOR Pathway Abberation
-
Aadi Bioscience, Inc.RecruitingMalignant Solid Neoplasm | Neoplasms | Cancer | Neoplasm Metastasis | Solid Tumor | Metastatic Cancer | Metastasis | Advanced Solid Tumor | Metastatic Solid Tumor | Advanced Cancer | Tumor | Malignant Neoplasm | Malignant Tumor | Tumors | Cancer Metastatic | Tumor, Solid | Malignant Solid Tumor | TSC | TSC1 | TSC2 | Metastatic NeoplasmKorea, Republic of, United States, Puerto Rico
-
University of Maryland, BaltimoreWellcome Trust; Bharat Biotech InternationalRecruiting
-
Dana-Farber Cancer InstituteNovartis PharmaceuticalsCompletedTuberous Sclerosis Complex | TSC1 | TSC2 | MTORUnited States
-
University of California, Los AngelesRecruiting
-
Erasmus Medical CenterUtrecht UniversityUnknownTuberous Sclerosis Complex | TSC Related Cognitive Disability | TSC Related Autism | TSC Related Learning ProblemsNetherlands
-
AOSpine EuropeCompletedAcute Spinal Cord Injury of Traumatic Origin (tSCI)United Kingdom, Ireland, Austria, Italy, Netherlands, Bulgaria, Croatia, France, Germany, Romania, Serbia, Turkey
-
Children's Hospital of Fudan UniversityShanghai Children's Medical Center; Xinhua Hospital of Shanghai Jiaotong UniversityWithdrawnTSC | DMD | X-ALD | XlsmaChina
-
University of North Carolina, Chapel HillUnited States Department of DefenseRecruiting
-
Sergiusz JozwiakMedical University of Vienna; Charite University, Berlin, Germany; Institut National... and other collaboratorsUnknownEpilepsy | Tuberous Sclerosis Complex | TSCPoland, Austria, Belgium, Czech Republic, France, Germany, Italy, Netherlands
-
Novartis PharmaceuticalsCompletedLymphangioleiomyomatosis (LAM) | Tuberous Sclerosis Complex (TSC)United States, United Kingdom, Germany, Italy, Russian Federation, Netherlands, Japan, Canada, Poland, France, Spain